Australija - engleski - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - epirubicin hydrochloride -

Australija - engleski - Department of Health (Therapeutic Goods Administration)

novotech australia pty ltd - epirubicin hydrochloride -

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - epirubicin hydrochloride 2 mg/ml;   - solution for injection - 2 mg/ml - active: epirubicin hydrochloride 2 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of: · breast cancer, · gastric cancer, · ovarian cancer, · small cell lung cancer, · lymphoma (non-hodgkin's lymphoma), · advanced/metastatic soft tissue sarcoma, and · superficial bladder cancer (tis; ta). in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3). epirubicin has also shown antitumour activity in the following tumours: · carcinoma of the oesophagus · primary hepatocellular carcinoma · pancreatic carcinoma · carcinoma of the head and neck · acute leukaemias and multiple myeloma

Irska - engleski - HPRA (Health Products Regulatory Authority)

accord healthcare limited - ondansetron - solution for inj/inf - 2 mg/ml - ondansetron

Malta - engleski - Malta Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - epirubicin hydrochloride - solution for infusion or injection - epirubicin hydrochloride 2 mg/ml - antineoplastic agents

Malta - engleski - Malta Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - epirubicin hydrochloride - solution for infusion or injection - epirubicin hydrochloride 2 mg/ml - antineoplastic agents

Malta - engleski - Malta Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - epirubicin hydrochloride - solution for infusion or injection - epirubicin hydrochloride 2 mg/ml - antineoplastic agents

Malta - engleski - Malta Medicines Authority

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - epirubicin hydrochloride - solution for infusion or injection - epirubicin hydrochloride 2 mg/ml - antineoplastic agents

Venezuela - španjolski - Instituto Nacional de Higiene

pfizer venezuela, s.a. - daunorubicina - solucion inyectable - 2 mg/ml

Australija - engleski - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - epirubicin hydrochloride, quantity: 200 mg - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, superficial bladder cancer (tis; ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grades 2 and 3).